Peter X. Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Peter X. Chen has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Michael A. Rogers
Department of Food Science University of Guelph Guelph ON Canada
2 shared publications - Jiahao Huang
School of Pharmacy, University of Waterloo, Waterloo, ON N2L3G1, Canada
1 shared publication Nawaz Ahmed
Department of Food Science, University of Guelph, Guelph, Ontario, N1G 2W1, Canada
1 shared publication- Paul A. Spagnuolo
Department of Food Science, University of Guelph, Guelph, ON N1G 2W1, Canada
1 shared publication - Richard W. Smith
University of Waterloo Mass Spectrometry Facility, Department of Chemistry, 200 University Avenue West, Waterloo, ON N2L 3G1, Canada
1 shared publication - Shawn David Wettig
School of Pharmacy, University of Waterloo, 200 University Ave. W., Waterloo, ON N2L 3G1, Canada
1 shared publication
Latest Publications
- Open Access
- 14 August 2024
- Published by Elsevier in Food Chemistry
- Vol. 463 (Pt 1) , 140811
Bioaccessibility of avocado polyhydroxylated fatty alcohols
- 14 August 2024
- Published by Elsevier in Food Chemistry
- Vol. 463 (Pt 1) , 140811
Open AccessBioaccessibility of avocado polyhydroxylated fatty alcohols
- Open Access
- 2 April 2019
- Published by MDPI AG in Pharmaceutics
- Vol. 11 (4) , 156
Investigating the Phospholipid Effect on the Bioaccessibility of Rosmarinic Acid-Phospholipid Complex through a Dynamic Gastrointestinal in Vitro Model
Phyto-phospholipid complexes have been developed as a common way of improving the oral bioavailability of poorly absorbable phyto-pharmaceuticals; however, the complexation with phospholipids can induce positive or negative effects on the bioaccessibility of such plant-derived active ingredients in different parts of the gastrointestinal tract (GIT). The purpose of this study was to investigate the effects of phospholipid complexation on the bioaccessibility of a rosmarinic acid-phospholipid complex (RA-PLC) using the TNO dynamic intestinal model-1 (TIM-1). Preparation of RA-PLC was confirmed using X-ray diffraction, Fourier-transform infrared spectroscopy, partition coefficient measurement, and Caco-2 monolayer permeation test. Bioaccessibility parameters in different GIT compartments were investigated. Complexation by phospholipids reduced the bioaccessibility of RA in jejunum compartment, while maintaining the ileum bioaccessibility. The overall bioaccessibility of RA-PLC was lower than the unformulated drug, suggesting that the improved oral absorption from a previous animal study could be considered as a net result of decreased bioaccessibility overwhelmed by enhanced intestinal permeability. This study provides insights into the effects of phospholipid on the bioaccessibility of hydrophilic compounds, and analyzes them based on the relationship between bioaccessibility, membrane permeability, and bioavailability. Additionally, TIM-1 shows promise in the evaluation of dosage forms containing materials with complicated effects on bioaccessibility.
- 2 April 2019
- Published by MDPI AG in Pharmaceutics
- Vol. 11 (4) , 156
Open AccessInvestigating the Phospholipid Effect on the Bioaccessibility of Rosmarinic Acid-Phospholipid Complex through a Dynamic Gastrointestinal in Vitro Model
Phyto-phospholipid complexes have been developed as a common way of improving the oral bioavailability of poorly absorbable phyto-pharmaceuticals; however, the complexation with phospholipids can induce positive or negative effects on the bioaccessibility of such plant-derived active ingredients in different parts of the gastrointestinal tract (GIT). The purpose of this study was to investigate the effects of phospholipid complexation on the bioaccessibility of a rosmarinic acid-phospholipid complex (RA-PLC) using the TNO dynamic intestinal model-1 (TIM-1). Preparation of RA-PLC was confirmed using X-ray diffraction, Fourier-transform infrared spectroscopy, partition coefficient measurement, and Caco-2 monolayer permeation test. Bioaccessibility parameters in different GIT compartments were investigated. Complexation by phospholipids reduced the bioaccessibility of RA in jejunum compartment, while maintaining the ileum bioaccessibility. The overall bioaccessibility of RA-PLC was lower than the unformulated drug, suggesting that the improved oral absorption from a previous animal study could be considered as a net result of decreased bioaccessibility overwhelmed by enhanced intestinal permeability. This study provides insights into the effects of phospholipid on the bioaccessibility of hydrophilic compounds, and analyzes them based on the relationship between bioaccessibility, membrane permeability, and bioavailability. Additionally, TIM-1 shows promise in the evaluation of dosage forms containing materials with complicated effects on bioaccessibility.